Collaboration in more than 46 countries.

You are leaving the country website to access another site in the group. Regulatory constraints and medical practices vary from country to country. Consequently, the information provided on the site in which you enter may not be suitable for use in your country.

NORTH AMERICA

Canada

United States

LATIN AMERICA

Argentina

Brazil

Mexico

Perú

GLOBAL

CEVA Global

EMEA (REGIONAL)

Denmark

Egypt

France

Germany

Hungary

Italy

Netherlands

Poland

Portugal

Romania

South Africa

Spain

Sweden

Tunisia

Turkey

Ukraine

United Kingdom

ASIA PACIFIC

Asia Pacific (Regional)

CHINA

India

Indonesia

Japan

Korea

Malaysia

Philippines

Share on:

Successful launch of Cevaxel RTU in China

On June 3rd, 2024, Ceva China ruminant business unit successfully hosted the Dairy Cow Uterus Disease Management Summit and Cevaxel RTU Launch Event in the city of Hangzhou. The event was attended by over 80 participants, including Ceva China’s top 20 customers. In addition, the event was streamed online, attracting more than 10,000 visits.

Introducing Cevaxel® RTU

Ceva’s new product, Cevaxel® RTU is designed for easy use and syringeability, raising the bar for ceftiofur hydrochloride products.

A summit featured in three chapters

The content of the conference was divided in three different chapters:

  • Win-win cooperation. This section described the sustainable farming path of Ceva ruminant business, the company vision of antibiotic use, the Cevolution program, and the protocol for treatment of bovine metritis and foot rot.
  • Chinese policy trends. New regulations on veterinary medicine registration and milk quality control were explained.
  • Expert Perspectives. This final chapter focused on the prevention and treatment of uterine diseases in dairy cows.

 

Commitment to the industry

At the end of the conference, Ceva China emphasized its ongoing commitment to providing high-quality products and tailor-made solutions. The launch of Cevaxel® RTU demonstrates Ceva China´s dedication to enhancing their product portfolio and contributing to the development of China´s dairy industry.

Check the list of the event speeches and speakers

  • Welcome and opening speech. Wanmeng LI, Ceva China Vice-president.
  • We See What You See. Juan Muñoz-Bielsa, Ceva Corporate Ruminant Franchise Vice President.
  • Smart Antibiotherapy by Ceva. Damien Achard, Ceva Ruminant Corporate Vet Service Manager.
  • Policy Interpretation to Reduce the Use of Antimicrobials in Food Animals. Shixin Xu, Researcher, China Institute of Veterinary Drug Control.
  • Policy Trend of Maximum Residue Limits of Veterinary Medicine in Milk. Xianhui Huang, Senior Veterinarian, South China Agricultural University; Deputy Director, National Veterinary Drug Residue Reference Laboratory.
  • Imported Veterinary Medicine Registration Policy Update, Taking Cevaxel® RTU as an Example. Haiyan Guo, Ceva China RA Manager.
  • Overview of Metritis and Endometritis in High-yielding Dairy Cows. Professor Geert R.G.Opsomer, Ghent University.
  • Managing and Monitoring the Health of Transition Dairy Cows. Chong MA, Senior Veterinarian, China Agricultural University.
  • Closing. Junke Feng, Ceva China Ruminant BU Head.

 

A special thank you to Taomei Li, Marketing Manager of Ceva China ruminant BU for planning and organizing this successful event.

This site is registered on wpml.org as a development site.